Welcome to our dedicated page for Tomi Environmental Solutions I news (Ticker: TOMZ), a resource for investors and traders seeking the latest updates and insights on Tomi Environmental Solutions I stock.
TOMI Environmental Solutions, Inc. reports developments tied to disinfection and decontamination products built around SteraMist iHP and Binary Ionization Technology. Company news commonly covers biocidal regulatory approvals, SteraMist applications in healthcare, life sciences, food safety, commercial facilities, transportation and remediation settings, and product categories such as BIT Solution consumables, integrated systems, mobile equipment and iHP Corporate Service offerings.
Updates also include operating and financial results, customer and service activity, training and application protocols, shareholder voting matters, governance topics, capital-structure disclosures and material agreements. TOMI's recurring business themes include the installed base for SteraMist delivery systems, consumable BIT Solution demand, engineered decontamination systems and professional decontamination services.
TOMI Environmental Solutions (NASDAQ: TOMZ) appointed Total Clean Air as its Preferred European Partner for SteraMist iHP, making TCA the primary provider for sales, service, and technical support across the UK and EU. The agreement adds in-region validation, consignment stock, a UK showroom, and a dedicated workshop to support GMP Annex 1 compliance and surge demand in life sciences.
Market context includes a UK infection control market projected to exceed $6 billion by 2031 and a UK sterility testing market forecast at a 14% CAGR through 2035.
TOMI Environmental Solutions (NASDAQ: TOMZ) received Health and Safety Executive authorizations GB-2016-1042 (Great Britain) and NI-2026-1350 (Northern Ireland) on Feb. 23, 2026, allowing its Binary Ionization Technology (BIT) and SteraMist iHP products for registered biocidal uses.
Approvals cover room fogging and handheld surface spray on dry, pre-cleaned, hard, non-porous surfaces across healthcare, industrial, hospitality, and institutional sectors; specific EN and AOAC efficacy contact times are listed for bactericidal, yeasticidal, and virucidal claims.
TOMI Environmental Solutions (NASDAQ: TOMZ) announced on Jan 20, 2026 the sale of a Custom Engineered System (CES) in the United Kingdom to an international pharmaceutical manufacturer. The CES integrates SteraMist iHP into Total Clean Air's modular cleanroom platform, the first deployment of iHP within that architecture. The integration is described as regulator-ready for MHRA and EMA expectations and intended to provide a repeatable, scalable decontamination model across pharmaceutical cleanrooms.
TOMI Environmental Solutions (NASDAQ: TOMZ) announced the purchase and installation of a SteraMist Hybrid System in a new sterilization facility at a private East Coast research university on January 6, 2026.
The system will be used for repeatable, high‑level decontamination of reusable medical equipment distributed to patient homes and is intended to maintain isolation and minimize manual intervention during sterilization phases. This unit is the second SteraMist Hybrid sale within a $13 million automated installation pipeline that includes Custom Engineered Systems and the SteraMist Integrated System platform.
TOMI Environmental Solutions (NASDAQ: TOMZ) announced on December 22, 2025 that a leading Cell and Gene Therapy manufacturer has adopted SteraMist ionized Hydrogen Peroxide (iHP) technology for a commercial-scale pharmaceutical facility.
The multi-stage implementation includes multiple SteraMist systems for surface treatment and automated room fogging, a full SOP development package, and an Installation and Operational Qualification (IQ/OQ) delivered by TOMI’s Qualification Team. TOMI’s iHP Corporate Service will perform whole-facility fogging across manufacturing suites, QC labs, and support spaces to support cGMP contamination control.
TOMI Environmental Solutions (NASDAQ: TOMZ) secured a signed purchase order valued at approximately $500,000 from a global biopharmaceutical leader to integrate the SteraMist iHP technology into passthrough fill boxes used in sterile manufacturing.
The contract covers full integration of the SteraMist Integrated Systems (SIS) platform across two manufacturing areas and includes comprehensive installation and performance qualification (PQ) services to meet regulatory validation requirements. The projects were previously included in a stated $13 million automated-installation pipeline, and TOMI expects further orders through 2026 and beyond.
TOMI Environmental Solutions (NASDAQ:TOMZ) on Dec. 15, 2025 urged cruise lines to adopt hospital-grade decontamination technology such as SteraMist to improve passenger and crew safety. TOMI highlighted cruise ships as concentrated, high‑risk environments for pathogens like Norovirus and Legionella and referenced recent outbreaks to argue for proactive, comprehensive disinfection beyond traditional cleaning.
The release says SteraMist can treat high‑risk areas (dining, crew quarters, clinics, children’s play areas, outdoor furniture), enable faster outbreak containment, reduce downtime, and increase passenger confidence. TOMI invites cruise operators and the public to partner with the company and provides contact info for assistance.
TOMI Environmental Solutions (NASDAQ:TOMZ) will present at the Sidoti Year End Investor Conference on December 11, 2025 at 2:30 PM ET. CEO Dr. Halden Shane and CFO David Vanston will be available for one-on-one meetings during the virtual conference on December 10-11, 2025. The presentation will cover TOMI's Binary Ionization Technology (BIT) platform and SteraMist product line for disinfection and decontamination.
Investors can register to watch the virtual presentation and contact investor relations at tomi@imsinvestorrelations.com for meeting requests.
TOMI Environmental Solutions (NASDAQ: TOMZ) announced a custom integration pipeline valued at approximately $3 million focused on life sciences and medical device customers. The company reports ten active projects across its SteraMist Integrated System (SIS) and Custom Engineered System (CES) platforms and multiple projects scheduled for completion before year-end.
Strategic partnerships with enclosure manufacturers including ESCO, Steelco, PBSC, Nuaire, and Getinge are cited as drivers of platform growth and broader distribution for integrated iHP decontamination solutions.
TOMI Environmental Solutions (NASDAQ: TOMZ) filed a $50 million universal shelf registration statement on Form S-3 with the SEC on November 17, 2025, enabling the company to offer and sell securities from time to time up to the aggregate amount once the shelf is declared effective.
Concurrent with the filing, TOMI entered a strategic advisory and placement arrangement with Bancroft Capital and established an equity line of credit (ELOC) with Hudson Global Ventures, LLC that allows TOMI to sell up to $20,000,000 of common stock over a 24-month period. Management cited Q3 sequential revenue growth, improved gross margins, and expanding adoption of SteraMist technology as drivers for pursuing added financing flexibility to support growth, manufacturing, product development, and global distribution.